Two diabetes drugs could become more affordable for Maryland residents, following a study by the Prescription Drug ...

DelveInsight's,“ Thyroid Cancer Pipeline Insight 2025” report provides comprehensive insights about 50+ companies and 51+ ...

The clinical benefits of exercise-based cardiac rehabilitation have been less clear for patients with Afib. A meta-analysis ...

With three decades of experience, Labinger will help advance the company’s scientific platform toward key clinical milestones ...

Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...

Foundation’s signature charity cycling and walking event – celebrated its 24th year with $1.69 million raised to date to help support cancer survivorship and patient navigation programs.

Fifty 1 Labs (OTC: FITY) , through its subsidiary Fifty1 AI Labs, LLC, announced the successful completion of the REVIVE Adaptive Platform Trial (NCT ...

AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

As Keytruda generic competition looms larger on the horizon, the company is hoping to reinvest the savings into pipeline ...

The newly formed biotech launches with five promising autoimmune candidates, $300 million in funding, and leadership from ...

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Best and Safe Dividend Stocks to Buy Now. Bristol-Myers Squibb Company (NYSE:BMY) presents a strong case for investors looking for both ...